Search clinical trials for: IBI 389 Injection
Total 12406 results
-
Chong Kun Dang PharmaceuticalUnknownHypertensionKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknown
-
University Hospitals, LeicesterJafron Biomedical Company LimitedNot yet recruitingPilot Study on HA380 Column Use in Critically Ill Patients Receiving Extracorporeal Support. (HACEC)Inflammation | Acute Kidney Injury | ARDS | Extracorporeal Circulation; ComplicationsUnited Kingdom
-
Vergent Bioscience, Inc.RecruitingLung Cancer | Lung MetastasesUnited States, Australia
-
Stanford UniversityStanford's Innovative Medicines AcceleratorRecruitingColorectal CancerUnited States
-
AbbVieActive, not recruiting
-
Novo Nordisk A/SCompleted
-
Hutchison Medipharma LimitedCompleted
-
AbbottTerminatedAttention-Deficit/Hyperactivity DisorderUnited States
-
AstraZenecaCompletedUncontrolled and Persistent AsthmaUnited Kingdom
-
Novo Nordisk A/SCompletedObesity | Diabetes Mellitus, Type 2 | Overweight | Healthy VolunteersNetherlands
-
LabrhaStatitecCompletedKnee OsteoarthritisFrance
-
Watson PharmaceuticalsCompletedAnemia, Iron-Deficiency | Kidney Failure, ChronicUnited States, Puerto Rico
-
Istituto Ortopedico RizzoliRecruitingKnee OsteoarthritisItaly
-
HutchmedActive, not recruitingLymphomaSpain, United States, France, Italy, Finland, Poland
-
Vergent Bioscience, Inc.National Cancer Institute (NCI)Completed
-
AbbVie (prior sponsor, Abbott)CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Tasly Pharmaceuticals, Inc.Completed
-
AbbottTerminatedAlzheimer's DiseaseUnited States
-
AbbottTerminatedA Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's DiseaseAlzheimer's DiseaseUnited States
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
HutchmedRecruitingRelapsed/Refractory LymphomaChina
-
Wyeth is now a wholly owned subsidiary of PfizerWithdrawn
-
Hutchison Medipharma LimitedCompleted
-
Chong Kun Dang PharmaceuticalUnknownType2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType II DiabetesKorea, Republic of
-
Jeil Pharmaceutical Co., Ltd.Completed
-
AbbVie (prior sponsor, Abbott)CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
AbbottCompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Western Galilee Hospital-NahariyaRecruiting
-
Chong Kun Dang PharmaceuticalNot yet recruitingCardiovascular DiseasesKorea, Republic of
-
Carmot Therapeutics, Inc.Carmot Australia First Pty LtdRecruiting
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2China
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAlzheimer Disease | Healthy SubjectsUnited States
-
Boston PharmaceuticalsCompletedDiarrhea-predominant Irritable Bowel SyndromeUnited States
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
TeneoOne Inc.RecruitingMultiple MyelomaIsrael, United States, Canada, Spain, France, Denmark, United Kingdom
-
AbbVieRecruitingFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Chronic Lymphocytic LeukemiaUnited States, Australia, Canada, Israel
-
Chong Kun Dang PharmaceuticalCompletedGERDKorea, Republic of
-
AbbVieCompletedAdvanced Solid Tumors CancerJapan
-
AbbVie (prior sponsor, Abbott)CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
AbbottCompletedHealthyUnited States
-
Rothman Institute OrthopaedicsUnknownTrigger Finger | Stenosing TenosynovitisUnited States
-
Yangzhou UniversityNot yet recruiting
-
Indiana University School of MedicineCompletedColorectal Cancer | Colorectal PolypsUnited States
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
National Center of Neurology and Psychiatry, JapanNippon Shinyaku Co., Ltd.Completed